Clinical Trial Update: A Study in Subjects With Perennial Allergic Rhinitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in perennial allergic rhinitis conducted by Merck Sharp & Dohme has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Perennial Allergic Rhinitis | Phase 2 | Status: COMPLETED